Efficacy of Combining Movement Representation Techniques to Active Neural Mobilization in the Mec… (NCT07154017) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Efficacy of Combining Movement Representation Techniques to Active Neural Mobilization in the Mechanosensitivity of the Median Nerve in Asymptomatic Volunteers.
Argentina10 participantsStarted 2025-09
Plain-language summary
The objective of this study will be to determine whether the combination of movement imaging techniques with neural mobilization (NM) exercises works to modify median nerve sensitivity to mechanical stimuli. Movement Representation Techniques (MRTs) are defined as therapeutic or training systems that neurophysiologically evoke a perceptual-cognitive representation of movement. They can be combined with the execution of actual movement or with afferent sensory stimulation (motor command). There is evidence demonstrating positive results in pain reduction and improved range of motion using MRTs alone.
The study will be evaluated in 10 randomly selected asymptomatic volunteers, considering the following variables: pressure pain threshold, elbow extensor range of motion, and sensory responses before and after the intervention, in both the experimental and control groups. The period between interventions will be 72 hours.
Who can participate
Age range
18 Years – 45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* asymptomatic volunteers of both sexes
* aged 18 to 45
* with no symptoms or history of disease in the cervical region, shoulder girdle, or upper limb.
Exclusion Criteria:
* history of surgery or trauma to the cervical spine, shoulder girdle, or upper limb;
* nonspecific shoulder pain;
* presenting symptoms of chronic pain in any region of the body;
* aphantasia (inability to create mental images);
* hypermobility;
* history of cancer or active disease;
* current infection;
* rheumatological disease;
* neurological and/or psychiatric disorders;
* altered sensation;
* current pregnancy;
* consumption of centrally acting medications;
* undergoing physiotherapy treatment in the last month;
* inability to understand the informed consent document;
* previous experience with median nerve provocation testing.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Elbow Extensor Range of Motion
Timeframe: Pre- and post-interventions with a 72-hour washout period, for both control and experimental.
2
Pressure Pain Threshold
Timeframe: Pre and post interventions, both control and experimentalPre- and post-interventions with a 72-hour washout period, for both control and experimental.
3
Spatiotemporal distribution of sensory responses
Timeframe: Pre- and post-interventions with a 72-hour washout period, for both control and experimental.